Cargando…
FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease
BACKGROUND: The development of therapeutic interventions for Parkinson disease (PD) is challenged by disease complexity and subjectivity of symptom evaluation. A Parkinson's Disease Related Pattern (PDRP) of glucose metabolism via fluorodeoxyglucose positron emission tomography (FDG-PET) has be...
Autores principales: | Matthews, Dawn C., Lerman, Hedva, Lukic, Ana, Andrews, Randolph D., Mirelman, Anat, Wernick, Miles N., Giladi, Nir, Strother, Stephen C., Evans, Karleyton C., Cedarbaum, Jesse M., Even-Sapir, Einat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120603/ https://www.ncbi.nlm.nih.gov/pubmed/30186761 http://dx.doi.org/10.1016/j.nicl.2018.08.006 |
Ejemplares similares
-
Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
por: Ben Bashat, Dafna, et al.
Publicado: (2022) -
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers
por: Droby, Amgad, et al.
Publicado: (2022) -
Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier
por: Matthews, Dawn C., et al.
Publicado: (2022) -
(99m)Tc-MDP bone scintigraphy of the hand: comparing the use of novel cadmium zinc telluride (CZT) and routine NaI(Tl) detectors
por: Koulikov, Victoria, et al.
Publicado: (2015) -
Beyond Visual Assessment of Basal Ganglia Uptake: Can Automated Method and Pineal Body Uptake Assessment Improve Identification of Nigrostriatal Dysfunction on (18)F-DOPA PET/CT?
por: Hazut Krauthammer, Shir, et al.
Publicado: (2023)